DEFC14A: Lifeway Foods Sets 2025 Annual Meeting Amidst Proxy Battle

Sentiment:

Definitive Proxy Statement 1 December 2025 2:00 PM

Lifeway Foods, Inc. announced its 2025 Annual Meeting of Shareholders, featuring a contested director election and proposals on corporate governance, executive compensation, and a shareholder-initiated strategic review.

Delay expectedIn 2024, the company's Board refreshment proceedings were delayed to allow time for the Board to review, negotiate, and address various shareholder-related activities.

Better than expectedNet Revenue in 2024 was $186.8 million, exceeding the minimum threshold of $145 million and the target of $150 million for the annual incentive program.Adjusted EBITDA in 2024 was $28.3 million, exceeding the maximum performance threshold of $25.5 million for the annual incentive program.Total shareholder return is 788% over the past five years, outperforming peers and the S&P 500.Revenue has grown approximately 100% since fiscal year 2019.Q3 2025 net sales of $57.1 million represent a 29% volume-led increase, marking six years of uninterrupted quarterly net sales growth.Q3 2025 gross margin expanded by 300 basis points and net income grew by 19%.

Summary

The 2025 Annual Meeting of Shareholders is scheduled for December 29, 2025, at 11:00 A.M. Central Time, and will be held virtually.
Shareholders will vote on the election of eight directors, with the Board recommending its slate against two opposition nominees, George Sent and Edward Smolyansky.
Proposals include amending the Articles of Incorporation to provide for director exculpation, indemnification, and expense advancement, ratifying Grant Thornton LLP as the independent auditor for fiscal year 2025, and a non-binding advisory vote on executive compensation.
The Board recommends an annual frequency for the say-on-pay vote and advises against a non-binding shareholder proposal to form a committee for management and strategic reviews.
The company entered a Cooperation Agreement with Danone North America PBC on September 30, 2025, regarding board refreshment and equity compensation.
Total shareholder return is 788% over the past five years, outperforming peers and the S&P 500.
Revenue has grown approximately 100% since fiscal year 2019.
Q3 2025 net sales reached $57.1 million, a 29% volume-led increase, marking six years of uninterrupted quarterly net sales growth.
Q3 2025 gross margin expanded by 300 basis points, and net income grew by 19%.
Julie Smolyansky received a $2,000,000 one-time cash retention bonus on December 23, 2024.
Amy Feldman's employment as Senior Executive Vice President Sales was terminated on February 28, 2025, as part of an organizational restructuring.

Sentiment

Score: 7

Explanation: The company demonstrates robust financial performance and growth, with significant shareholder returns. However, the ongoing proxy contest and related party transactions introduce governance concerns and potential distractions, slightly tempering overall positive sentiment.

Positives

Total shareholder return of 788% over the past five years, outperforming peers and the S&P 500.
Revenue growth of approximately 100% since fiscal year 2019.
Six years of uninterrupted quarterly net sales growth, with Q3 2025 net sales at $57.1 million (29% volume-led increase).
Q3 2025 gross margin expansion of 300 basis points and net income growth of 19%.
The Board refreshment process is ongoing, increasing independence and expertise, with a majority of New Independent Board Members expected by June 30, 2026.
Implementation of a clawback policy for executive compensation effective November 9, 2023, to support accountability.
An Executive and Director Stock Ownership and Holding Policy is in place to align interests with shareholders.
CEO Julie Smolyansky and CFO Eric Hanson satisfied executive officer stock ownership requirements as of January 1, 2025.
An independent Chairperson (Dorri McWhorter) was appointed in October 2025, enhancing independent oversight.
The Audit and Corporate Governance Committee and Compensation Committee are composed solely of independent directors.
Engagement of an independent compensation consultant (Aon) for executive and non-employee director compensation review.
Strong shareholder engagement efforts, including meetings with top shareholders, are ongoing.

Negatives

A contested director election is ongoing, with Edward Smolyansky nominating opposition candidates, leading to a proxy battle.
Edward Smolyansky's shareholder proposal suggests a failure of proper oversight by the current Board, potentially harming shareholder liquidity.
Edward Smolyansky and Ludmila Smolyansky have repeatedly advocated for a sale, even when the stock was at $5.07 per share in February 2022.
The company expended management and financial resources related to challenges from Edward Smolyansky and Ludmila Smolyansky, with additional solicitation costs for the proxy contest estimated at approximately $250,000.
Amy Feldman's employment as Senior Executive Vice President Sales was terminated on February 28, 2025, as part of an organizational restructuring.
Several directors and executive officers had delinquent Section 16(a) reports, including Jason Scher, Pol Sikar, Julie Smolyansky, Amy Feldman, Eric Hanson, and Edward Smolyansky.
Julie Smolyansky's equity awards may be settled in cash instead of equity due to the Cooperation Agreement with Danone, unless Danone consents or its consent right terminates.
Eric Hanson's equity awards may also be settled in cash under similar conditions due to the Cooperation Agreement with Danone.

Risks

Risk of disruption and cost associated with the ongoing proxy contest and shareholder activism from Edward Smolyansky.
Potential for directors to be deterred from serving due to personal liability exposure and litigation costs if exculpation and indemnification amendments are not approved.
Risks associated with management succession planning, though the Board reviews this annually.
Cybersecurity risks and data protection failures could impact operations and trust.
Risk that compensation practices do not incentivize desired outcomes, though the Compensation Committee manages this.
Risk of competitive disadvantage if long-term financial targets for PSUs are disclosed.
Risk of losing key personnel if compensation is not competitive.
Pending litigation matters involving the company, including between the Company and Danone relating to the Stockholders Agreement.

Future Outlook

The company aims to continue profitable growth, expand product distribution, and develop the Lifeway brand. The Compensation Committee will continue to review how to appropriately compensate the CEO without issuing equity compensation in accordance with the Cooperation Agreement. The company intends to continue its shareholder engagement program. The Board expects to amend the Bylaws to limit indemnification rights for director-initiated actions following the Annual Meeting.

Management Comments

The Board strongly recommends that you vote on the WHITE proxy card FOR the election of the Boards nominees, FOR Proposal Two, FOR Proposal Three, FOR Proposal Four, for a frequency of EVERY ONE YEAR for Proposal Five and AGAINST Proposal Six.
The Board does not endorse the Opposition Nominees and unanimously recommends that you vote FOR the election of each of the nominees on the Boards Slate and WITHHOLD any vote for the Opposition Nominees on the enclosed WHITE proxy card or voting instruction form.
The Board strongly urges you NOT to sign or return any proxy card sent to you by ES.
Shareholders consistently praised the Company's leadership for its strong performance and strong execution during this challenging period.
The Compensation Committee will continue to review how to appropriately compensate our CEO without issuing equity compensation in accordance with the terms of the Cooperation Agreement.
The Company has grown significantly and consistently since 2019 under the leadership of Julie Smolyansky and the Board.

Industry Context

Lifeway Foods operates in the dynamic health food, wellness, and consumer packaged goods (CPG) sectors, specializing in dairy and probiotic products like kefir. The company's reported strong growth and strategic focus on expanding its product distribution align with increasing consumer demand for functional and healthy foods. The ongoing board refreshment and governance changes reflect broader industry trends towards enhanced corporate accountability and responsiveness to shareholder activism. The company's superior performance, evidenced by a 788% TSR over five years and 100% revenue growth since 2019, indicates strong execution in a competitive market, positioning it favorably against industry peers.

Comparison to Industry Standards

Total shareholder return of 788% over the past five years significantly outperforms peers and the S&P 500, indicating superior market performance.
The company's consistent net sales growth, gross margin expansion, and net income growth in Q3 2025 suggest strong operational execution relative to industry averages, especially during challenging periods.
The engagement of Aon, an independent compensation consultant, and the annual review of the peer group (including companies like Celsius Holdings, Freshpet, and Zevia PBC) demonstrate an effort to align executive compensation with competitive industry standards for mid-cap food, beverage, and natural wellness companies.

Management Changes

Role	Previous Person	New Person	Effective Date	Reason
Chairperson of the Board	Julie Smolyansky	Dorri McWhorter	2025-10-01	Transition to an independent Chairperson as part of Board policy and refreshment.
Director	Jody Levy	NA	2025-10-01	Resigned from the Board.
Director	Perfecto Sanchez	NA	2025-11-01	Resigned from the Board.
Director	NA	Kirk Chartier	2025-11-01	Elected as a Director as part of Board refreshment.
Director	NA	Susie Hultquist	2025-11-01	Elected as a Director as part of Board refreshment.
Director	NA	Rachel Drori	2025-10-01	Elected as a Director as part of Board refreshment.
Director	NA	Andee Harris	2025-10-01	Elected as a Director as part of Board refreshment.
Senior Executive Vice President Sales	Amy Feldman	NA	2025-02-28	Termination as part of organizational restructuring, elimination of position.
Audit and Corporate Governance Committee Member	Pol Sikar	NA	2025-11-01	Removed from committee.
Audit and Corporate Governance Committee Member	NA	Andee Harris	2025-11-01	Appointed as a member.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Board Leadership Structure	Transitioned from the CEO serving as Chairperson to an independent Chairperson (Dorri McWhorter) in October 2025. The independent Chairperson now performs functions previously handled by the Lead Independent Director.	2025-10-01	Enhances independent oversight of management and promotes better communication among management and between management and the Board.
Director Exculpation and Indemnification	Proposed amendments to the Articles of Incorporation to provide for customary director exculpation and indemnification to the fullest extent permitted by Illinois law, including expense advancement.	Upon filing of amended articles (if approved)	Aims to attract and retain qualified directors by reducing personal liability exposure and litigation risk, potentially lowering insurance costs. Will not apply to existing litigation.
Board Refreshment	Ongoing process to replace long-serving directors and add new independent directors with diverse skills and experience, as per a Cooperation Agreement with Danone. By June 30, 2026, the Board will have a majority of New Independent Board Members.	Ongoing, with key changes in Oct/Nov 2025 and by June 30, 2026	Increases Board independence, breadth of experience, and effectiveness, addressing shareholder concerns about oversight.
Clawback Policy	Adopted a policy for forfeiture and recoupment of certain executive compensation in the event of a required accounting restatement due to material noncompliance with financial reporting requirements.	2023-11-09	Strengthens accountability among the management team and aligns compensation with accurate financial reporting.
Stock Ownership and Holding Policy	Requires executive officers to own Lifeway Common Stock valued at 200% of their annual base salary and non-employee directors to own 200% of their annual Board retainer, with retention requirements for net shares received from equity awards.	Ongoing, compliance evaluated annually on Jan 1st	Aligns the interests of executive officers and non-employee directors with those of shareholders, promoting sound corporate governance.
Insider Trading Policy	Prohibits trading while in possession of material, nonpublic information and restricts short sales, hedging, derivatives, margin buying, and pledging of stock without prior approval for Pre-Clearance Persons.	In effect	Designed to promote compliance with insider trading laws and regulations, and applicable Nasdaq listing standards.
Audit and Corporate Governance Committee Structure	Combined audit and nominating committees into a single Audit and Corporate Governance Committee, composed solely of independent directors. The committee oversees internal controls, financial reporting, auditor selection, and director nominations.	In effect	Streamlines committee structure, ensures independent oversight of financial and governance matters, and enhances efficiency.
Strategic Review Committee	The Strategic Review Committee was dissolved.	2025-11-01	Indicates a shift in how strategic reviews are conducted, potentially integrating them into broader Board functions or other committees.

Legal Proceedings

Pending litigation between the Company and Danone North America PBC relating to the Stockholders Agreement.
The proposed director exculpation and indemnification amendments would not apply to or have any effect on existing legal proceedings.

Related Party Transactions

Jason Burdeen, Julie Smolyansky's spouse, is employed as the CEO's Chief of Staff. In 2024, his total compensation was $313,800, including a base salary of $200,000, a $100,000 cash bonus, allowances, and equity awards (RSUs and PSUs).
Julie Smolyansky received a $2,000,000 one-time cash retention bonus on December 23, 2024, with a repayment obligation if she terminates employment without Good Reason before December 20, 2026.
Julie Smolyansky's equity awards may be settled in cash instead of equity due to the Cooperation Agreement with Danone, unless Danone consents or its consent right terminates.
Eric Hanson's equity awards may also be settled in cash under similar conditions due to the Cooperation Agreement with Danone.

Stakeholder Impact

Shareholders are directly impacted by the proxy contest, director elections, and proposals on corporate governance and executive compensation. Strong financial performance and TSR are positive, but the proxy battle and related costs are a negative.
Employees are affected by executive compensation policies, potential organizational restructuring (Amy Feldman's termination), and the overall strategic direction of the company.
Management is impacted by executive compensation, retention bonuses, and equity awards. The proxy contest creates additional workload and potential distraction.
Customers are indirectly impacted by the company's strategic plan, product development, and distribution efforts, which aim for profitable growth.
Creditors benefit from the company's strong financial health and stability, as reflected in robust performance metrics.
Regulatory authorities are concerned with the company's compliance with SEC rules, including Section 16(a) reports and proxy statement disclosures.

Next Steps

Hold the 2025 Annual Meeting of Shareholders on December 29, 2025, to vote on director elections and proposals.
File amended and restated articles of incorporation with the Illinois Secretary of State if Proposal Two (director exculpation and indemnification) is approved.
The Board expects to amend the Bylaws to limit indemnification rights for director-initiated actions following the Annual Meeting.
The Compensation Committee will continue to review CEO compensation in light of the Cooperation Agreement with Danone.
Continue the shareholder engagement program.
Hold the 2026 Annual Meeting of Shareholders on or prior to June 30, 2026.
The Board will be made up of a majority of New Independent Board Members by June 30, 2026.
Jason Scher will not be nominated for re-election at the 2026 Annual Meeting.

Key Dates

Date	Description
1986-05-19	Date of incorporation of Lifeway Foods, Inc.
1999-10-01	Date of the original Stockholders Agreement between the Company, Danone Foods, Inc., Michael Smolyansky, Ludmila Smolyansky, Julie Smolyansky and Edward Smolyansky.
2002-06-01	Julie Smolyansky appointed as Director, President, and CEO following the death of Michael Smolyansky.
2002-08-01	Julie Smolyansky served as CFO and Treasurer from 2002 to 2004.
2003-01-01	Eric Hanson's employment with Crowe Horwath began (through 2012).
2004-01-01	Eric Hanson served as Audit Manager for Deloitte & Touche, LLP (through 2014).
2012-07-01	Jason Scher elected as a Director of the Company.
2013-01-01	Dorri McWhorter became CEO of YWCA Metropolitan Chicago (until 2021).
2013-01-01	Kirk Chartier began serving as Chief Marketing Officer or Chief Strategy Officer of Enova International, Inc. (since 2013).
2014-01-01	Rachel Drori founded Daily Harvest (until 2024).
2014-01-01	Eric Hanson served as Director of External Reporting for The Azek Company (through July 2016).
2015-01-01	Susie Hultquist founded Spokin (since 2015).
2016-03-29	Lifeway filed registration statement on Form S-8 for 2015 Omnibus Plan.
2016-07-01	Eric Hanson became Corporate Controller.
2018-05-01	Eric Hanson became Chief Accounting Officer and interim Chief Financial Officer.
2018-10-29	Amy Feldman's employment agreement dated.
2018-11-01	Eric Hanson permanently appointed Chief Financial Officer.
2019-01-01	Say on Frequency vote held, with 62.8% of shareholders voting for every three years.
2020-01-01	Julie Smolyansky appointed Secretary.
2020-08-01	Dorri McWhorter elected as a Director.
2021-01-01	Dorri McWhorter became CEO of YMCA Chicago (until 2025).
2022-08-01	Juan Carlos (JC) Dalto elected as a Director.
2022-08-31	Shareholders adopted the 2022 Omnibus Incentive Plan and 2022 Non-Employee Director Equity and Deferred Compensation Plan.
2022-12-06	Audit and Corporate Governance Committee first engaged Grant Thornton LLP as independent auditor.
2023-05-24	Company filed registration statement on Form S-8 for 2022 Omnibus Plan.
2023-10-02	Effective date for clawback policy for incentive compensation.
2023-11-09	Clawback policy adopted by the Board.
2024-01-01	Executive officers and non-employee directors stock ownership compliance evaluated.
2024-01-10	Date of RSU and PSU awards for Jason Burdeen, Julie Smolyansky, Eric Hanson, and Amy Feldman.
2024-03-14	Annual Report on Form 10-K for fiscal year ended December 31, 2024, filed with the SEC.
2024-11-04	Rights Declaration Date for Series A Junior Participating Preferred Stock.
2024-12-23	Julie Smolyansky entered into a Retention Bonus Agreement.
2024-12-28	Deadline for online/QR code proxy voting for the 2025 Annual Meeting (10:59 P.M. Central Time).
2024-12-28	Deadline to register to attend the virtual Annual Meeting (11:00 A.M. Central Time).
2024-12-31	End of fiscal year 2024.
2025-01-01	Executive officers and non-employee directors stock ownership compliance evaluated.
2025-01-10	First vesting date for 2024 RSU awards.
2025-02-28	Amy Feldman's employment terminated.
2025-03-13	Audit and Corporate Governance Committee approved appointment of Grant Thornton LLP as independent auditor for FY2025.
2025-06-16	Separation Agreement between Amy Feldman and the Company dated.
2025-06-24	Vesting date for some of Amy Feldman's RSUs and PSUs per Separation Agreement.
2025-07-01	First vesting date for non-employee director restricted stock awards.
2025-08-01	Andee Harris became CEO of Crisis Prevention Institute (since August 2025).
2025-09-30	Cooperation Agreement between the Company and Danone North America PBC dated.
2025-10-01	Rachel Drori and Andee Harris elected as Directors.
2025-10-01	Dorri McWhorter became Chairperson of the Board (since October 2025).
2025-10-01	Jody Levy resigned from the Board.
2025-11-01	Kirk Chartier and Susie Hultquist elected as Directors.
2025-11-01	Perfecto Sanchez resigned from the Board.
2025-11-01	Pol Sikar removed from Audit and Corporate Governance Committee.
2025-11-05	Record date for the 2025 Annual Meeting.
2025-12-01	Proxy statement, accompanying proxy card, and Annual Report on Form 10-K for FY2024 first sent to shareholders.
2025-12-29	Date of the 2025 Annual Meeting of Shareholders (11:00 A.M. Central Time).
2026-01-06	Deadline for shareholder proposals for the 2026 Annual Meeting to be included in proxy statement.
2026-02-12	Earliest date for shareholder written notice for proposals/nominations for 2026 Annual Meeting not included in proxy statement.
2026-03-14	Latest date for shareholder written notice for proposals/nominations for 2026 Annual Meeting not included in proxy statement.
2026-04-13	Deadline for shareholders to provide notice for soliciting proxies for director nominees for 2026 Annual Meeting under universal proxy rules.
2026-06-16	Vesting date for some of Amy Feldman's RSUs and PSUs per Separation Agreement.
2026-06-30	Deadline for the 2026 Annual Meeting of Shareholders to be held.
2026-12-20	Date after which Julie Smolyansky's repayment obligation for retention bonus terminates if she leaves without Good Reason.
2026-12-31	End of 3-year measurement period for 2024 PSU awards.

Recommendation

hold

Lifeway Foods demonstrates robust financial performance, including significant revenue growth and strong total shareholder returns, which would typically warrant a 'buy' recommendation. However, the ongoing and costly proxy contest, coupled with the termination of a senior executive and the complexities surrounding CEO equity compensation due to the Danone agreement, introduce notable governance and operational uncertainties. While the company's fundamentals are strong, these internal conflicts and potential distractions suggest a 'hold' position until the resolution of the proxy battle and clearer strategic alignment are established, allowing investors to assess the long-term impact of these governance challenges.

Keywords

Lifeway Foods, LWAY, Proxy Statement, Annual Meeting, Director Election, Corporate Governance, Executive Compensation, Shareholder Proposal, Proxy Contest, Danone, Kefir, Food & Beverage, SEC Filing, Financial Performance, Board Refreshment, Risk Management, Equity Compensation, Retention Bonus

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.